This study is part of the Rico Macro-Project, a multidisciplinary research program promoted by FROM in collaboration with the ASST-PG23 and ATS Bergamo, aiming to investigate the role of clonal hematopoiesis on inflammation, studying in depth the mechanisms underlying the inflammatory process to determine their correlation with some important pathologies in different clinical fields (Hematology, Cardiology, Neurology, Pneumology, Gastroenterology, and Diabetology, etc.). In this context, the prospective observational study RICO-HF is developed. The RICO HF is the first project focused on CHIP and inflammation in the area of Cardiology, specifically in HF.
CHIP is associated with a pro-inflammatory state and its mechanistic link to HF has been demonstrated in animal and cellular models, and in patient cohorts (14-24). Although HF in humans has various causes, different pathophysiological mechanisms and heterogeneous clinical manifestations, the experimental and clinical data reported so far support the relevance of inflammatory cytokine production and signaling by immune cells in the pathogenesis of cardiac dysfunction and HF.
Study Type
OBSERVATIONAL
Enrollment
300
Each patient, consecutively afferent to the SC Cardiologia I of the ASST-PG23 in Bergamo with the diagnosis of acute or chronic HF, at enrollment will undergo to routine clinical and instrumental examination.
ATS BERGAMO Agenzia di Tutela della Salute
Bergamo, Italy
ACTIVE_NOT_RECRUITINGAsst Papa Giovanni Xxiii - Dip. Di Cardiologia
Bergamo, Italy
RECRUITINGEvaluate the prevalence of CHIP in patients with a diagnosis of acute HF according to the value of LVEF>50% (HFpEF) or ≤50% (HFmrEF/HFrEF) at the time of hospitalization.
Obtained by medical health records
Time frame: At diagnosis during the baseline
Estimation of CHIP prevalence in patients with acute HFpEF, by de novo and worsening conditions
Obtained by medical health records
Time frame: At baseline; 1 year follow-up.
Estimation of CHIP prevalence in HF patients, according to the acute or chronic conditions and classified by LVEF
Obtained by medical health records
Time frame: At baseline; 1 year follow-up.
Association between CHIP and patterns of inflammatory biomarkers in patients with acute de novo HFpEF
Obtained by medical health records
Time frame: At baseline; 1 year follow-up.
Association between CHIP and outcome (mortality, urgent heart transplant, HF hospitalization and need for urgent visit due to HF decompensation)
Obtained by medical health records
Time frame: At baseline; 1 year follow-up.
Association between CHIP and patients' clinical characteristics at baseline
Obtained by medical health records
Time frame: At baseline; 1 year follow-up.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.